A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David P Rosenbaum, Ph.D.
Ardelyx, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
117 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ardelyx Investigative Site 257
Dothan, Alabama, United States
- Ardelyx Investigative Site 200
Foley, Alabama, United States
- Ardelyx Investigative Site 100
Huntsville, Alabama, United States
- Ardelyx Investigative Site 103
Huntsville, Alabama, United States
- Ardelyx Investigative Site 244
Huntsville, Alabama, United States
- Ardelyx Investigative Site 251
Huntsville, Alabama, United States
- Ardelyx Investigative Site 209
Saraland, Alabama, United States
- Ardelyx Investigative Site 210
Phoenix, Arizona, United States
- Ardelyx Investigative Site 296
Phoenix, Arizona, United States
- Ardelyx Investigative Site 256
Tucson, Arizona, United States
- Ardelyx Investigative Site 269
Tucson, Arizona, United States
- Ardelyx Investigative Site 292
Conway, Arkansas, United States
- Ardelyx Investigative Site 122
Little Rock, Arkansas, United States
- Ardelyx Investigative Site 163
Anaheim, California, United States
- Ardelyx Investigative Site 105
Canoga Park, California, United States
- Ardelyx Investigative Site 143
Chula Vista, California, United States
- Ardelyx Investigative Site 147
Encino, California, United States
- Ardelyx Investigative Site 297
La Mesa, California, United States
- Ardelyx Investigative Site 284
La Mirada, California, United States
- Ardelyx Investigative Site 107
Lomita, California, United States
- Ardelyx Investigative Site 165
Long Beach, California, United States
- Ardelyx Investigative Site 211
Orange, California, United States
- Ardelyx Investigative Site 233
Wheat Ridge, Colorado, United States
- Ardelyx Investigative Site 212
Bristol, Connecticut, United States
- Ardelyx Investigative Site 176
Brandon, Florida, United States
- Ardelyx Investigative Site 178
Cutler Bay, Florida, United States
- Ardelyx Investigative Site 130
Hialeah, Florida, United States
- Ardelyx Investigative Site 136
Hialeah, Florida, United States
- Ardelyx Investigative Site 191
Lynn Haven, Florida, United States
- Ardelyx Investigative Site 106
Miami, Florida, United States
- Ardelyx Investigative Site 288
Miami, Florida, United States
- Ardelyx Investigative Site 127
Miami Lakes, Florida, United States
- Ardelyx Investigative Site 179
Orlando, Florida, United States
- Ardelyx Investigative Site 290
Tampa, Florida, United States
- Ardelyx Investigative Site 254
West Palm Beach, Florida, United States
- Ardelyx Investigative Site 138
Atlanta, Georgia, United States
- Ardelyx Investigative Site 148
Atlanta, Georgia, United States
- Ardelyx Investigative Site 253
Atlanta, Georgia, United States
- Ardelyx Investigative Site 229
Decatur, Georgia, United States
- Ardelyx Investigative Site 272
Decatur, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2015
- Primary completion
- 31 Aug 2017
- Completion
- 31 Oct 2017
- Last update posted
- 22 Apr 2020
- Registered enrollment
- 593
- Registry id
- NCT02686138
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.